Literature DB >> 3917980

In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase.

J Jacquot, J M Tournier, E Puchelle.   

Abstract

The in vitro effects of Pseudomonas aeruginosa elastase (P. aeruginosa E) and of human leukocyte elastase on human airway lysozyme (HAL) were investigated. P. aeruginosa E inactivated and cleaved HAL, whereas human leukocyte elastase had no effect. Total inactivation of HAL by P. aeruginosa E was observed after 120 min of incubation at 37 degrees C, for an elastase-to-lysozyme molar ratio of 1:5. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of reaction mixtures containing HAL and P. aeruginosa E in an elastase-to-lysozyme molar ratio of 1:10 showed a progressive disappearance of the HAL band upon increasing the incubation time with P. aeruginosa E. Gel filtration chromatography indicated that HAL was cleaved into at least three peptide fragments. The cleavage of HAL by P. aeruginosa E was accompanied by parallel losses of its bacteriolytic activity and its immunoreactive property.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917980      PMCID: PMC263208          DOI: 10.1128/iai.47.2.555-560.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  NMR and enzymatic investigation of the interaction between elastase and sodium trifluoroacetate.

Authors:  C Winninger; P Lestienne; J L Dimicoli; J G Bieth
Journal:  Biochim Biophys Acta       Date:  1978-09-11

2.  Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysosomal enzymes.

Authors:  A D Glick; J M Ranhand; R M Cole
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

3.  Tissue distribution of lysozyme in man.

Authors:  M Klockars; S Reitamo
Journal:  J Histochem Cytochem       Date:  1975-12       Impact factor: 2.479

4.  [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].

Authors:  G Döring; H J Obernesser; K Botzenhart
Journal:  Zentralbl Bakteriol A       Date:  1981-03

5.  Pseudomonas colonization in cystic fibrosis. A study of 160 patients.

Authors:  L L Kulczycki; T M Murphy; J A Bellanti
Journal:  JAMA       Date:  1978-07-07       Impact factor: 56.272

6.  Alpha,-antitrypsin and leukocyte elastase in infected and noninfected sputum.

Authors:  R A Stockley; D Burnett
Journal:  Am Rev Respir Dis       Date:  1979-11

7.  The importance of lysozyme for the viscosity of sputum from patients with chronic obstructive lung disease.

Authors:  A O Jenssen; O Smidsrød; O Harbitz
Journal:  Scand J Clin Lab Invest       Date:  1980       Impact factor: 1.713

8.  Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase.

Authors:  D A Johnson; B Carter-Hamm; W M Dralle
Journal:  Am Rev Respir Dis       Date:  1982-12

9.  Quantitation of proteins in sputum from patients with chronic obstructive lung disease. II. Determination of albumin, transferrin, alpha1-acid glycoprotein, IgG, IgM, lysozyme and C3-complement factor.

Authors:  H K Kotlar; O Harbitz; A O Jenssen; O Smidsrød
Journal:  Eur J Respir Dis       Date:  1980-08

10.  Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.

Authors:  L L Blackwood; R M Stone; B H Iglewski; J E Pennington
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.609

View more
  20 in total

1.  Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.

Authors:  L W Heck; K Morihara; D R Abrahamson
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.

Authors:  Ganapathi Iyer Parameswaran; Sanjay Sethi; Timothy F Murphy
Journal:  Chest       Date:  2011-02-24       Impact factor: 9.410

4.  Isolation and characterization of an elastinolytic proteinase from Aspergillus flavus.

Authors:  J C Rhodes; T W Amlung; M S Miller
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

5.  Heterogeneous virulence potential and high antibiotic resistance of Pseudomonas aeruginosa strains isolated from Korean pneumonia patients.

Authors:  Mi Young Yoon; Kang-Mu Lee; Seok Hoon Jeong; Jungmin Kim; Sang Sun Yoon
Journal:  J Microbiol       Date:  2010-08-20       Impact factor: 3.422

6.  Survival and growth of Ajellomyces (Blastomyces) dermatitidis on oak leaves coated with saliva.

Authors:  E S McDonough; D J Hierl
Journal:  Mycopathologia       Date:  1987-07       Impact factor: 2.574

Review 7.  Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

8.  Detection of elastase production in Escherichia coli with the elastase structural gene from several non-elastase-producing strains of Pseudomonas aeruginosa.

Authors:  E Tanaka; S Kawamoto; J Fukushima; K Hamajima; H Onishi; Y Miyagi; S Inami; K Morihara; K Okuda
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

9.  Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.

Authors:  G Döring; W Goldstein; A Röll; P O Schiøtz; N Høiby; K Botzenhart
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

10.  Effect of Pseudomonas aeruginosa elastase B on level and activity of immune proteins/peptides of Galleria mellonella hemolymph.

Authors:  Mariola Andrejko; Magdalena Mizerska-Dudka
Journal:  J Insect Sci       Date:  2012       Impact factor: 1.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.